Amyloid and amyloidoses: differences, common themes, and practical considerations
- PMID: 1924282
Amyloid and amyloidoses: differences, common themes, and practical considerations
Abstract
Amyloidosis is not one entity but a grouping of disorders in all of which there is a tissue protein deposit with similar morphological, structural, and staining properties despite involving fundamentally different proteins or peptides. Each protein is involved in its own specific pathogenetic mechanism. These mechanisms determine, in a manner as yet unknown, which protein will be present in an amyloid deposit. The role of proteolysis in the pathogenesis is questioned. Proteolysis may well be a postfibrillogenic event. Local tissue factors, such as the basement membrane form of heparan sulfate proteoglycan, in addition to perhaps other basement membrane components, may play an important role in the genesis of amyloid. Differences, common themes, and various unanswered questions related to the pathogenesis of the amyloids are presented as are practical diagnostic considerations.
Similar articles
-
Review: amyloidogenesis-unquestioned answers and unanswered questions.J Struct Biol. 2000 Jun;130(2-3):99-108. doi: 10.1006/jsbi.2000.4222. J Struct Biol. 2000. PMID: 10940218 Review.
-
Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.Ann N Y Acad Sci. 2005 Dec;1066:181-221. doi: 10.1196/annals.1363.030. Ann N Y Acad Sci. 2005. PMID: 16533927 Review.
-
Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism: implications for therapeutic strategies against amyloidosis.Cell Biochem Biophys. 2002;36(2-3):191-207. doi: 10.1385/CBB:36:2-3:191. Cell Biochem Biophys. 2002. PMID: 12139405 Review.
-
Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications.Amyloid. 2007 Mar;14(1):21-32. doi: 10.1080/13506120601116419. Amyloid. 2007. PMID: 17453622 Review.
-
Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it.Acta Histochem. 2006;108(3):197-208. doi: 10.1016/j.acthis.2006.03.010. Epub 2006 Jun 21. Acta Histochem. 2006. PMID: 16790262
Cited by
-
Anti-amyloid drugs: potential in the treatment of diseases associated with aging.Drugs Aging. 1996 Feb;8(2):75-83. doi: 10.2165/00002512-199608020-00001. Drugs Aging. 1996. PMID: 8845588 Review.
-
Amyloid goiter related with Crohn's disease: A rare association: Amyloid goiter secondary to Crohn's disease.Int J Surg Case Rep. 2014;5(8):480-3. doi: 10.1016/j.ijscr.2014.06.004. Epub 2014 Jun 10. Int J Surg Case Rep. 2014. PMID: 24981166 Free PMC article.
-
Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt).Hum Genet. 2015 Jan;134(1):111-21. doi: 10.1007/s00439-014-1499-0. Epub 2014 Nov 4. Hum Genet. 2015. PMID: 25367359 Free PMC article.
-
The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance.Turk J Haematol. 2017 Dec 1;34(4):282-288. doi: 10.4274/tjh.2017.0197. Epub 2017 Aug 23. Turk J Haematol. 2017. PMID: 28832010 Free PMC article. Review.
-
Juvenile rheumatoid arthritis with amyloid goiter: report of a case with review of the literature.Endocr Pathol. 2001 Winter;12(4):437-41. doi: 10.1385/ep:12:4:437. Endocr Pathol. 2001. PMID: 11914477
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical